93
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates

, , , , , & show all
Pages 113-126 | Published online: 07 May 2019

References

  • Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376(26):2566–2578. doi:10.1056/NEJMra160754728657875
  • Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–2078. doi:10.1056/NEJMra080464719923578
  • Adelman DC, Murray J, Wu TT, Maki M, Green PH, Kelly CP. Measuring change in small intestinal histology in patients with celiac disease. Am J Gastroenterol. 2018;113(3):339–347. doi:10.1038/ajg.2017.48029460921
  • Sheibani S, Gerson LB. Chemical colitis. J Clin Gastroenterol. 2008;42(2):115–121. doi:10.1097/MCG.0b013e318151470e18209577
  • Papaconstantinou HT, Thomas JS. Bacterial colitis. Clin Colon Rectal Surg. 2007;20(1):18–27. doi:10.1055/s-2007-97019620011357
  • Gecse KB, Vermeire S. Differential diagnosis of inflammatory bowel disease: imitations and complications. lancet Gastroenterol hepatol. 2018;3(9):644–653. doi:10.1016/S2468-1253(18)30159-630102183
  • Devos D, Lebouvier T, Lardeux B, et al. Colonic inflammation in Parkinson’s disease. Neurobiol Dis. 2013;50:42–48. doi:10.1016/j.nbd.2012.09.00723017648
  • Houser MC, Chang J, Factor SA, et al. Stool immune profiles evince gastrointestinal inflammation in Parkinson’s Disease. Mov Disord. 2018;33(5):793–804. doi:10.1002/mds.2732629572994
  • Weimers P, Halfvarson J, Sachs MC, et al. Inflammatory Bowel Disease and Parkinson’s Disease: a nationwide swedish cohort study. Inflamm Bowel Dis. 2019;25(1):111–123. doi:10.1093/ibd/izy190
  • Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014. Gut. 2019;68(1):18–24. doi:10.1136/gutjnl-2017-315666
  • Zhu F, Li C, Gong J, Zhu W, Gu L, Li N. The risk of Parkinson’s disease in inflammatory bowel disease: a systematic review and meta-analysis. Dig Liver Dis. 2018.
  • Peter I, Dubinsky M, Bressman S, et al. Anti-tumor necrosis factor therapy and incidence of parkinson disease among patients with inflammatory Bowel Disease. JAMA Neurol. 2018;75(8):939–946. doi:10.1001/jamaneurol.2018.060529710331
  • Lai SW, Liao KF, Lin CL, Sung FC. Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan. Eur J Epidemiol. 2014;29(1):57–62. doi:10.1007/s10654-014-9878-324442494
  • Palma JA, Kaufmann H. Autonomic disorders predicting Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(Suppl 1):S94–S98. doi:10.1016/S1353-8020(13)70024-524262198
  • Gao X, Chen H, Schwarzschild MA, Ascherio A. A prospective study of bowel movement frequency and risk of Parkinson’s disease. Am J Epidemiol. 2011;174(5):546–551. doi:10.1093/aje/kwr11921719744
  • Vermilyea SC, Emborg ME. Alpha-synuclein and nonhuman primate models of Parkinson’s disease. J Neurosci Methods. 2015;255:38–51. doi:10.1016/j.jneumeth.2015.07.02526247888
  • Bendor JT, Logan TP, Edwards RH. The function of α-synuclein. Neuron. 2013;79(6):1044–1066. doi:10.1016/j.neuron.2013.09.00424050397
  • Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Mol Neurobiol. 2013;47(2):495–508. doi:10.1007/s12035-012-8280-y22622968
  • Unal-Cevik I, Gursoy-Ozdemir Y, Yemisci M, et al. Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse. J Cereb Blood Flow Metab. 2011;31(3):913–923. doi:10.1038/jcbfm.2010.17020877387
  • Acosta SA, Tajiri N, de la Pena I, et al. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson’s disease. J Cell Physiol. 2015;230(5):1024–1032. doi:10.1002/jcp.2483025251017
  • Almandoz-Gil L, Welander H, Ihse E, et al. Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of alpha-synuclein through different pathways. Free Radic Biol Med. 2017;110:421–431. doi:10.1016/j.freeradbiomed.2017.07.00428690195
  • David JM, Dick EJ Jr., Hubbard GB. Spontaneous pathology of the common marmoset (Callithrix jacchus) and tamarins (Saguinus oedipus, Saguinus mystax). J Med Primatol. 2009;38(5):347–359. doi:10.1111/j.1600-0684.2009.00362.x19522731
  • Shultz JM, Resnikoff H, Bondarenko V, et al. Neurotoxin-induced catecholaminergic loss in the colonic myenteric plexus of rhesus monkeys. J Alzheimers Dis Parkinsonism. 2016;6:6. doi:10.4172/2161-0460
  • Bernardini N, Segnani C, Ippolito C, et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med. 2012;16(2):318–327. doi:10.1111/j.1582-4934.2011.01298.x21426484
  • Belkind-Gerson J, Hotta R, Nagy N, et al. Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism. Inflamm Bowel Dis. 2015;21(4):870–878. doi:10.1097/MIB.000000000000032625742399
  • Cheon SM, Ha MS, Park MJ, Kim JW. Nonmotor symptoms of Parkinson’s disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord. 2008;14(4):286–290. doi:10.1016/j.parkreldis.2007.09.00218042421
  • Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG. Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol. 2012;124(5):665–680. doi:10.1007/s00401-012-1040-222941241
  • Corbille AG, Coron E, Neunlist M, Derkinderen P, Lebouvier T. Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD. J Parkinsons Dis. 2014;4(4):571–576. doi:10.3233/JPD-14042225055959
  • Ludlage E, Mansfield K. Clinical care and diseases of the common marmoset (Callithrix jacchus). Comp Med. 2003;53(4):369–382.14524413
  • Otovic P, Smith S, Hutchinson E. The use of glucocorticoids in marmoset wasting syndrome. J Med Primatol. 2015;44(2):53–59. doi:10.1111/jmp.1215925614344
  • Perepelov AV, Wang Q, Senchenkova SN, et al. Structure and gene cluster of the O-antigen of Escherichia coli O102. Carbohydr Res. 2012;361:73–77. doi:10.1016/j.carres.2012.07.02422982615
  • Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation. 2010;7:37. doi:10.1186/1742-2094-7-5920615234
  • Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 2002;123(6):1972–1979. doi:10.1053/gast.2002.3705912454854
  • Pontell L, Castelucci P, Bagyanszki M, et al. Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. Virchows Arch. 2009;455(1):55–65. doi:10.1007/s00428-009-0795-x19517133
  • von Boyen GB, Schulte N, Pfluger C, Spaniol U, Hartmann C, Steinkamp M. Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterol. 2011;11:3. doi:10.1186/1471-230X-11-9321235736
  • Clairembault T, Kamphuis W, Leclair-Visonneau L, et al. Enteric GFAP expression and phosphorylation in Parkinson’s disease. J Neurochem. 2014;130(6):805–815. doi:10.1111/jnc.1274224749759
  • Oueslati A. Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? J Parkinsons Dis. 2016;6(1):39–51. doi:10.3233/JPD-16077927003784
  • Hilton D, Stephens M, Kirk L, et al. Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease. Acta Neuropathol. 2014;127(2):235–241. doi:10.1007/s00401-013-1214-624240814
  • Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett. 2006;396(1):67–72. doi:10.1016/j.neulet.2005.11.01216330147
  • Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA. alpha-Synuclein in gut endocrine cells and its implications for Parkinson’s disease. JCI Insight. 2017;2:12. doi:10.1172/jci.insight.88864
  • Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13(1):21. doi:10.1186/s13024-018-0257-529751824
  • Manfredsson FP, Luk KC, Benskey MJ, et al. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis. 2018;112:106–118. doi:10.1016/j.nbd.2018.01.00829341898
  • Pan-Montojo F, Schwarz M, Winkler C, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012;2:898. doi:10.1038/srep0038623205266
  • Peng C, Gathagan RJ, Lee VM. Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies. Neurobiol Dis. 2018;109(Pt B):209–218. doi:10.1016/j.nbd.2017.07.01828751258
  • Svensson E, Horvath-Puho E, Thomsen RW, et al. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78(4):522–529. doi:10.1002/ana.2444826031848
  • Liu B, Fang F, Pedersen NL, et al. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology. 2017;88(21):1996–2002. doi:10.1212/WNL.000000000000396128446653
  • Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B. Treatment for Helicobacter pylori infection and risk of Parkinson’s disease in Denmark. Eur J Neurol. 2012;19(6):864–869. doi:10.1111/j.1468-1331.2011.03643.x22248366
  • Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? NPJ Parkinsons Dis. 2017;3:3. doi:10.1038/s41531-016-0002-028649603
  • Killinger BA, Madaj Z, Sikora JW, et al. The vermiform appendix impacts the risk of developing Parkinson’s disease. Sci Transl Med. 2018;10:465. doi:10.1126/scitranslmed.aao4496
  • Chen SG, Stribinskis V, Rane MJ, et al. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and caenorhabditis elegans. Sci Rep. 2016;6:34477. doi:10.1038/srep3447727708338
  • Stolzenberg E, Berry D, Yang D, et al. A role for neuronal alpha-synuclein in gastrointestinal immunity. J Innate Immun. 2017;9(5):456–463. doi:10.1159/00047799028651250